Is cbdMD Inc (YCBD) a Winner in the Drug Manufacturers - Specialty & Generic Industry?

Tuesday, June 30, 2020 10:34 AM | InvestorsObserver Analysts

cbdMD Inc (YCBD) is around the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. YCBD received an overall rating of 60, which means that it scores higher than 60 percent of all stocks. cbdMD Inc also achieved a score of 89 in the Drug Manufacturers - Specialty & Generic industry, putting it above 89 percent of Drug Manufacturers - Specialty & Generic stocks. Drug Manufacturers - Specialty & Generic is ranked 127 out of the 148 industries.

Overall Score - 60
YCBD has an Overall Score of 60. Find out what this means to you and get the rest of the rankings on YCBD!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 60 would rank higher than 60 percent of all stocks.

This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With cbdMD Inc Stock Today?

cbdMD Inc (YCBD) stock is trading at $1.80 as of 10:31 AM on Tuesday, Jun 30, an increase of $0.03, or 1.69% from the previous closing price of $1.77. The stock has traded between $1.78 and $1.83 so far today. Volume today is low. So far 171,209 shares have traded compared to average volume of 3,241,732 shares.

To see the top 5 stocks in Drug Manufacturers - Specialty & Generic click here.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

Related Companies